Theriva Biologics, Inc. (TOVX)
0.2326
+0.01
(+5.01%)
USD |
NYAM |
Dec 11, 16:00
0.2289
0.00 (0.00%)
After-Hours: 06:03
Theriva Biologics Research and Development Expense (Quarterly): 2.551M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -- |
| Palatin Technologies, Inc. | 2.526M |
| Oragenics, Inc. | 0.9309M |
| NanoViricides, Inc. | 0.9931M |
| Actinium Pharmaceuticals, Inc. | 4.042M |